Esophagitis and Barrett esophagus: Unifying the definitions and diagnostic approaches, with special reference to esophageal atresia

Journal of Pediatric Gastroenterology and Nutrition

Volumn 52, Issue SUPPL. 1, 2011, Pages

  Hassall, Eric ^a  

^a Sutter Pacific Medical Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; ENDOSCOPY; ESOPHAGUS ATRESIA; HUMAN; PREVALENCE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS;

BARRETT ESOPHAGUS; CHRONIC DISEASE; DISEASE MANAGEMENT; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL ATRESIA; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HUMANS; POSTOPERATIVE COMPLICATIONS; PREVALENCE;

EID: 79955550880     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182133143     Document Type: Article

References (43)

1. Hassall E. Barrett's esophagus: new definitions and approaches in children. J Pediatr Gastroenterol Nutr 1993;16:345-64. (Pubitemid 23143760)
2. Snyder JD, Goldman H. Barrett's esophagus in children and young adults. Frequent association with mental retardation. Dig Dis Sci 1990;35:1185-9. (Pubitemid 20377936)
3. Hassall E. Co-morbidities in childhood Barrett's esophagus. J Pediatr Gastroenterol Nutr 1997;25:255-60. (Pubitemid 27375414)
4. Romero Y, Cameron AJ, Schaid DJ, et al. Barrett's esophagus: prevalence in symptomatic relatives. Am J Gastroenterol 2002;97:1127-32. (Pubitemid 34478109)
5. Hassall E. Outcomes of fundoplication: causes for concern, newer options. Arch Dis Child 2005;90:1047-52. (Pubitemid 41406613)
6. Hassall E, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr 2007;150:262-7.
7. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidencebased consensus. Am J Gastroenterol 2006;101:1900-20.
8. Sherman P, Hassall E, Fagundes-Neto U, et al. A global evidence-based consensus on the definition of gastroesophageal reflux disease in children. Am J Gastroenterol 2009;104:1278-95.
9. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2009;49:498-547.
10. Hassall E, Dimmick JE, Magee JF. Adenocarcinoma in childhood Barrett's esophagus: case documentation and the need for surveillance in children. Am J Gastroenterol 1993;88:282-8. (Pubitemid 23053487)
11. Sharma P. Clinical practice. Barrett's esophagus. N Engl J Med 2009; 361:2548-56.
12. Spechler SJ, Fitzgerald RC, Prasad GA, et al. History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology 2010;138:854-69.
13. Weinstein WM, Ippoliti AF. The diagnosis of Barrett's esophagus: goblets, goblets, goblets. Gastrointest Endosc 1996;44:91-5. (Pubitemid 26268669)
14. Bremner CG, Lynch VP, Ellis FH Jr. Barrett's esophagus: congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery 1970;68:209-16.
15. Fitzgerald RC. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation? Gut 2005;54(Suppl 1):i21-6. (Pubitemid 40293005)
16. Gillen P, Keeling P, Byrne PJ, et al. Experimental columnar metaplasia in the canine oesophagus. Br J Surg 1988;75:113-5. (Pubitemid 18078523)
17. Peitz U, Vieth M, Pross M, et al. Cardia-type metaplasia arising in the remnant esophagus after cardia resection. Gastrointest Endosc 2004;59:810-7. (Pubitemid 38879307)
18. Hassall E. Cardia-type mucosa as an esophageal metaplastic condition in children: "Barrett's esophagus, intestinal metaplasia-negative." J Pediatr Gastroenterol Nutr 2008;47:102-6.
19. Liu W, Hahn H, Odze RD, et al. Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium. Am J Gastroenterol 2009;104:816-24.
20. Riddell RH, Odze RD. Definition of Barrett's esophagus: time for a rethink-is intestinal metaplasia dead? Am J Gastroenterol 2009;104: 2588-94.
21. Ofman JJ, Shaheen NJ, Desai AA, et al. The quality of care in Barrett's esophagus: endoscopist and pathologist practices. Am J Gastroenterol 2001;96:876-81. (Pubitemid 32240748)
22. Cameron AJ. Barrett's esophagus: prevalence and size of hiatal hernia. Am J Gastroenterol 1999;94:2054-9. (Pubitemid 29374531)
23. Chandrasoma PT, Der R, Dalton P, et al. Distribution and significance of epithelial types in columnar-lined esophagus. Am J Surg Pathol 2001; 25:1188-93. (Pubitemid 32777719)
24. Qualman SJ, Murray RD, McClung HJ, et al. Intestinal metaplasia is age related in Barrett's esophagus. Arch Pathol Lab Med 1990;114:1236-40.
25. Cheu HW, Grosfeld JL, Heifetz SA, et al. Persistence of Barrett's esophagus in children after antireflux surgery: influence on follow-up care. J Pediatr Surg 1992;27:260-4. discussion 265-6.
26. Cooper JE, Spitz L,Wilkins BM. Barrett's esophagus in children: a histologic and histochemical study of 11 cases. J Pediatr Surg 1987;22:191-6. (Pubitemid 17024541)
27. Lindahl H, Rintala R, Sariola H, et al. Cervical Barrett's esophagus: a common complication of gastric tube reconstruction. J Pediatr Surg 1990;25:446-8. (Pubitemid 20120421)
28. Othersen HB Jr, Ocampo RJ, Parker EF, et al. Barrett's esophagus in children. Diagnosis and management. Ann Surg 1993;217:676-80. discussion 680-1.
29. Krug E, Bergmeijer JH, Dees J, et al. Gastroesophageal reflux and Barrett's esophagus in adults born with esophageal atresia. Am J Gastroenterol 1999;94:2825-8. (Pubitemid 29485396)
30. Deurloo JA, Ekkelkamp S, Bartelsman JF, et al. Gastroesophageal reflux: prevalence in adults older than 28 years after correction of esophageal atresia. Ann Surg 2003;238:686-9. (Pubitemid 38182259)
31. Pultrum BB, Bijleveld CM, de Langen ZJ, JT P. Development of an adenocarcinoma of the esophagus 22 years after primary repair of a congenital atresia. J Pediatr Surg 2005;40:e1-e4. (Pubitemid 41774194)
32. Adzick NS, Fisher JH,Winter HS, et al. Esophageal adenocarcinoma 20 years after esophageal atresia repair. J Pediatr Surg 1989;24:741-4. (Pubitemid 19193712)
33. Alfaro L, Bermas H, Fenoglio M, et al. Are patients who have had a tracheoesophageal fistula repair during infancy at risk for esophageal adenocarcinoma during adulthood? J Pediatr Surg 2005;40:719-20.
34. Deurloo JA, van Lanschot JJ, Drillenburg P, et al. Esophageal squamous cell carcinoma 38 years after primary repair of esophageal atresia. J Pediatr Surg 2001;36:629-30. (Pubitemid 32268355)
35. LaQuaglia MP, Gray M, Schuster SR. Esophageal atresia and antethoracic skin tube esophageal conduits: squamous cell carcinoma in the conduit 44 years following surgery. J Pediatr Surg 1987;22:44-7. (Pubitemid 17216967)
36. Castilloux J, Bouron-Dal Soglio D, Faure C. Endoscopic assessment of children with esophageal atresia: lack of relationship of esophagitis and esophageal metaplasia to symptomatology. Can J Gastroenterol 2010;24:312-6.
37. Sistonen SJ, Koivusalo A, Nieminen U, et al. Esophageal morbidity and function in adults with repaired esophageal atresia with tracheoesophageal fistula: a population-based long-term follow-up. Ann Surg 2010; 251:1167-73.
38. Taylor AC, Breen KJ, Auldist A, et al. Gastroesophageal reflux and related pathology in adults who were born with esophageal atresia: a long-term follow-up study. Clin Gastroenterol Hepatol 2007;5:702-6. (Pubitemid 46830062)
39. El-Serag HB, Aguirre TV, Davis S, et al. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol 2004;99:1877-83. (Pubitemid 39421227)
40. Nguyen DM, Richardson P, El-Serag HB. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology 2010;138:2260-6.
41. Lundell L, Miettinen P, Myrvold HE, et al. Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis. Clin Gastroenterol Hepatol 2009;7:1292-8.
42. Spechler SJ. Surgery for gastroesophageal reflux disease: esophageal impedance to progress? Clin Gastroenterol Hepatol 2009;7:1264-5.
43. Reid BJ, Blount PL, Rubin CE, et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992;102: 1212-9.